Taiwan FDA registration 3e18a4ec1cccb3ee05d3b608e6d08621

"Eme Const" immunofluorescent staining antinuclear antibody-RO detection system

TW: “伊目康斯特” 免疫螢光染色抗核抗體-Ro檢測系統

Taiwan·Risk Class 2·IMMUNO CONCEPTS NA LTD·Registered Feb 10, 2015 – Feb 10, 2030Active

Registration details

Analysis ID: 3e18a4ec1cccb3ee05d3b608e6d08621
Customs Code: DHA05602706900

Company information

Manufacturer: IMMUNO CONCEPTS NA LTD
Manufacturer Country: United States
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Semi-quantitative detection of antinuclear antibodies in human serum by indirect immunofluorescent antibody detection.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5100 抗核抗體免疫試驗系統
Import Information: import

Dates and status

Registration Date: Feb 10, 2015
Expiry Date: Feb 10, 2030

About this record

Access comprehensive regulatory information for "Eme Const" immunofluorescent staining antinuclear antibody-RO detection system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3e18a4ec1cccb3ee05d3b608e6d08621 and manufactured by IMMUNO CONCEPTS NA LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.